Sigma receptors and cancer: possible involvement of ion channels.
The sigma (sigma) receptor and its agonists have been implicated in a myriad of cellular functions, biological processes and diseases. Whereas the precise molecular mechanism(s) of sigma receptors and their involvement in cancer cell biology have not been elucidated, recent work has started to shed some light on these issues. A molecular model has been proposed for the cloned sigma1 receptor; the precise molecular nature of the sigma2 receptor remains unknown. sigma receptors have been found to be frequently up-regulated in human cancer cells and tissues. sigma2 receptor drugs particularly have been shown to have antiproliferative effects. An interesting possibility is that sigma and/or sigma1 drugs could produce anticancerous effects by modulating ion channels. As well as proliferation, a variety of other metastatic cellular behaviors such as adhesion, motility, and secretion may also be affected. Other mechanisms of sigma receptor action may involve interaction with ankyrin and modulation of intracellular Ca(2+) and sphingolipid levels. Although more research is needed to further define the molecular physiology of sigma receptors, their involvement in the cellular pathophysiology of cancer raises the possibility that sigma drugs could be useful as novel therapeutic agents.
Department of Biological Sciences, Sir Alexander Fleming Building, Imperial College, South Kensington Campus, London SW7 2AZ, United Kingdom. e.aydar@imperial.ac.uk
Ebru
E
Aydar
Christopher P
CP
Palmer
Mustafa B A
MB
Djamgoz
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007473:Ion Channels / Q000502:physiology*; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology; D017480:Receptors, sigma / Q000378:metabolism*
D000970:Antineoplastic Agents; D007473:Ion Channels; D017480:Receptors, sigma